Analisis Keuangan Saham FBIOP - Fortress Biotech, Inc.

Gambaran Umum

Fortress Biotech, Inc., based in the United States, operates predominantly within the biopharmaceutical sector, focusing on the development and commercialization of novel pharmaceutical therapies. The company's business model hinges on developing partnerships with the biotechnology industry, leveraging their expertise to establish and support a diverse portfolio of project subsidiaries. Key projects typically involve the innovation of treatment options for rare diseases and hard-to-treat conditions, highlighting Fortress Biotech's commitment to addressing unmet medical needs. Their strategic approach integrates in-licensing, developing, and potentially commercializing cutting-edge therapeutic products, often navigating through the complex regulatory landscapes that characterize the pharmaceutical industry.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai revenue untuk Fortress Biotech, Inc. - Preferred Stock per 2025 Jun 30 adalah 59.30 MM.
Nilai operating income untuk Fortress Biotech, Inc. - Preferred Stock per 2025 Jun 30 adalah -100.08 MM.
Nilai net income untuk Fortress Biotech, Inc. - Preferred Stock per 2025 Jun 30 adalah -14.73 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	59.30	-100.08	-14.73
2025-03-31	57.78	-88.75	-41.16
2024-12-31	57.67	-103.00	-46.00
2024-09-30	81.50	-81.27	-48.51
2024-06-30	82.62	-91.93	-40.69
2024-03-31	85.11	-113.75	-54.52
2023-12-31	84.51	-136.06	-60.64
2023-09-30	61.97	-193.22	-78.31
2023-06-30	62.75	-214.40	-95.77
2023-03-31	64.25	-218.36	-92.35
2022-12-31	75.74	-203.56	-86.58
2022-09-30	77.61	-210.93	-91.19
2022-06-30	82.17	-201.12	-89.46
2022-03-31	81.13	-193.05	-71.64
2021-12-31	68.79	-179.00	-64.70
2021-09-30	64.26	-141.30	-38.43
2021-06-30	52.65	-120.22	-33.20
2021-03-31	44.27	-102.76	-42.98
2020-12-31	45.60	-94.27	-46.53
2020-09-30	42.98	-100.35	-56.72
2020-06-30

Laporan Laba Rugi: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31	-2.20	-2.20
2024-12-31	-2.69
2024-09-30	-3.49	-3.49
2024-06-30	-3.67	-3.67
2024-03-31	-5.89	-5.89
2023-12-31	-8.47
2023-09-30	-12.45	-12.45
2023-06-30	-15.89	-15.89
2023-03-31	-16.24	-16.24
2022-12-31	-15.97
2022-09-30	-16.74	-16.74
2022-06-30	-16.49	-16.49
2022-03-31	-13.29	-13.29
2021-12-31	-11.88
2021-09-30	-7.14	-7.14
2021-06-30	-6.27	-6.27
2021-03-31	-8.44	-8.44
2020-12-31	-9.69
2020-09-30	-12.70	-12.70
2020-06-30	-13.02	-13.02

Arus Kas: Operasi, Investasi, Pendanaan

Nilai cash from operating activities untuk Fortress Biotech, Inc. - Preferred Stock per 2025 Jun 30 adalah -80.09 MM.
Nilai cash from investing activities untuk Fortress Biotech, Inc. - Preferred Stock per 2025 Jun 30 adalah -7.75 MM.
Nilai kas dari aktivitas pendanaan untuk Fortress Biotech, Inc. - Preferred Stock per 2025 Jun 30 adalah 85.18 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	-80.09	-7.75	85.18
2025-03-31	-74.37	-13.84	94.92
2024-12-31	-80.19	-15.00	70.64
2024-09-30	-102.22	-0.06	88.45
2024-06-30	-98.94	4.94	83.06
2024-03-31	-110.39	2.90	38.41
2023-12-31	-128.22	-2.10	32.74
2023-09-30	-141.13	-2.43	7.74
2023-06-30	-167.63	-8.32	14.17
2023-03-31	-175.76	-6.59	47.54
2022-12-31	-179.40	-22.93	75.32
2022-09-30	-170.25	30.82	95.64
2022-06-30	-148.68	24.17	98.86
2022-03-31	-141.71	19.64	120.27
2021-12-31	-116.54	40.51	148.99
2021-09-30	-98.33	-14.41	147.07
2021-06-30	-100.53	-9.62	186.93
2021-03-31	-83.48	-5.85	228.35
2020-12-31	-83.68	-7.16	172.41
2020-09-30	-88.25	-5.29	162.55
2020-06-30

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30

Efektivitas Manajemen

roa untuk Fortress Biotech, Inc. - Preferred Stock pada 2025 Jun 30 adalah -0.28.
roic untuk Fortress Biotech, Inc. - Preferred Stock pada 2025 Jun 30 adalah -0.39.
croic untuk Fortress Biotech, Inc. - Preferred Stock pada 2025 Jun 30 adalah 0.06.
ocroic untuk Fortress Biotech, Inc. - Preferred Stock pada 2025 Jun 30 adalah -0.70.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2025-06-30	-0.28		-0.39	0.06	-0.70
2025-03-31	-0.25		-0.38	0.06	-0.68
2024-12-31	-0.27	-28.98	-0.62	-0.33	-1.08
2024-09-30	-0.32		-0.77	-0.22	-1.63
2024-06-30	-0.21	-2.75	-0.64	-0.82	-1.30
2024-03-31		-1.21
2023-12-31			-9.65	-16.74
2023-09-30			-16.27	-27.48
2023-06-30		-0.65	-16.27	-27.48
2023-03-31		-0.48	-2.13	-3.11
2022-12-31
2022-09-30
2022-06-30		-0.36
2022-03-31		-0.29	-0.33
2021-12-31		0.00
2021-09-30	0.00	0.00
2021-06-30	-0.12		-0.34	0.78	-1.02
2021-03-31	-0.19	-0.57	-0.13	0.41	-0.24
2020-12-31	-0.21	-0.64	-0.16	0.29	-0.29
2020-09-30	-0.26	-0.76	-0.20	0.25	-0.32
2020-06-30	-0.24	-0.60	-0.23	0.15	-0.35

Gross Margins

marjin kotor untuk Fortress Biotech, Inc. - Preferred Stock pada 2025 Jun 30 adalah 0.04.
marjin bersih untuk Fortress Biotech, Inc. - Preferred Stock pada 2025 Jun 30 adalah -0.71.
marjin operasi untuk Fortress Biotech, Inc. - Preferred Stock pada 2025 Jun 30 adalah -1.54.

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2025-06-30	0.04	-0.71	-1.54
2025-03-31	0.04	-0.71	-1.54
2024-12-31	-0.35	-0.80	-1.79
2024-09-30	-0.05	-0.60	-1.04
2024-06-30	-0.39	-0.64	-1.37
2024-03-31		-0.72	-1.65
2023-12-31
2023-09-30		-1.53	-3.42
2023-06-30		-1.53	-3.42
2023-03-31		-1.44	-3.35
2022-12-31
2022-09-30
2022-06-30
2022-03-31		-0.88	-2.34
2021-12-31
2021-09-30
2021-06-30
2021-03-31	-0.89	-0.97	-2.32
2020-12-31	-0.73	-1.02	-2.07
2020-09-30	-0.08	-1.32	-2.33
2020-06-30	0.70	-1.25	-2.31

Analisis Keuangan Saham FBIOP - Fortress Biotech, Inc. - Preferred Stock (NasdaqCM) Stock